Momenta Pharmaceuticals Stock News

Craig Wheeler has been the CEO of Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) since 2006. This report will, first...

We screen the Russell 2000 stocks to highlight the biggest winners in 2020. Several healthcare company stocks benefiting from the coronavirus pandemic are among

Alliancebernstein L.P. raised its holdings in shares of Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) by 2.2% in the fourth quarter, according to the company in its most recent disclosure with the Secur

Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) has received a consensus recommendation of “Buy” from the twelve research firms that are currently covering the company, Marketbeat Ratings reports. Thr

Norges Bank purchased a new stake in Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund

AQR Capital Management LLC bought a new stake in Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & E

Craig Wheeler became the CEO of Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) in 2006. This analysis aims first to...

The market remains unsettled but is moving higher as it expects good things to happen after the hot spots peak. The impact of the pandemic will keep expanding d

Macquarie Group Ltd. cut its stake in shares of Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) by 2.1% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional inv

In a report released today, Derek Archila from Stifel Nicolaus reiterated a Buy rating on Momenta Pharma (MNTA). The company's shares closed last Tuesday

In a report released today, Derek Archila from Stifel Nicolaus reiterated a Buy rating on Momenta Pharma ( MNTA – Research Report ). The company’s shares closed last Tuesday at $26.49. According t

The short- and long-term outlook is good, but mid-term risks are high. Here's what you can do now. Healthcare, consumer goods, and financials are the best secto

Coronavirus is probably the 1 concern in investors' minds right now. It should be. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW. We predicted

Coronavirus is probably the 1 concern in investors' minds right now. It should be. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW. We predicted

We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was